• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAB 10.0% 0.9¢

PATRYS LIMITED - Announcements

Patrys Limited is an Australia-based company, which is focused on the development of its... Patrys Limited is an Australia-based company, which is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company's deoxymab platform is based on the deoxymab 3E10 antibody that was identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus. It has developed two humanized forms of deoxymab 3E10, both of which have improved activity over the original deoxymab 3E10 antibody: PAT-DX1, which is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, and PAT-DX3, which is a full-sized Immunoglobulin G antibody. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. Its PAT-DX1- nanoparticles (NP) pipeline involves using its PAT-DX1 to develop a new drug based on the targeted delivery of NP carrying therapeutic payloads to the inside of cancer cells.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


PAB Change of Director's Interest Notice22/03/24 download Created with Sketch. 193.98KB
PAB Notification of cessation of securities - PAB22/03/24 download Created with Sketch. 12.8KB
PAB Presentation to highlight broader potential of Deoxymabs04/03/24 download Created with Sketch. 217.21KB
PAB Appendix 4D - Half Year Accounts - 31 December 2023PRICE SENSITIVE23/02/24 download Created with Sketch. 457.19KB
PAB Appendix 4C - Quarterly - 31 December 2023PRICE SENSITIVE23/01/24 download Created with Sketch. 517.63KB
PAB Change of Director's Interest Notice22/12/23 download Created with Sketch. 247.88KB
PAB GMP Production of PAT-DX1 Next QuarterPRICE SENSITIVE13/12/23 download Created with Sketch. 217.51KB
PAB Change of Director's Interest Notices x229/11/23 download Created with Sketch. 392.63KB
PAB Notification of cessation of securities - PAB29/11/23 download Created with Sketch. 21.63KB
PAB Amended Constitution15/11/23 download Created with Sketch. 1.23MB
PAB Results of Annual General Meeting15/11/23 download Created with Sketch. 582.64KB
PAB Chair's Address and CEO Presentation to 2023 AGM15/11/23 download Created with Sketch. 8.36MB
PAB Notification of Expiry of PABOA Listed Options13/11/23 download Created with Sketch. 369.9KB
PAB Patrys Receives R&D Tax Incentive RefundPRICE SENSITIVE08/11/23 download Created with Sketch. 217KB
PAB Appendix 4C - Quarterly - 30 September 2023PRICE SENSITIVE20/10/23 download Created with Sketch. 487.36KB
PAB Data to be presented at leading brain cancer conference19/10/23 download Created with Sketch. 281.69KB
PAB Notice of Annual General Meeting/Proxy Form12/10/23 download Created with Sketch. 712.96KB
PAB Final Director's Interest Notice20/09/23 download Created with Sketch. 372.26KB
PAB Retirement of Non-Executive Director14/09/23 download Created with Sketch. 218.44KB
PAB Appendix 4G and Corporate Governance Statement28/08/23 download Created with Sketch. 781.65KB
PAB Appendix 4E and 2023 Annual ReportPRICE SENSITIVE28/08/23 download Created with Sketch. 11.45MB
PAB Change of Director's Interest Notice11/08/23 download Created with Sketch. 271.58KB
PAB Application for quotation of securities - PAB08/08/23 download Created with Sketch. 24.94KB
PAB Application for quotation of securities - PAB26/07/23 download Created with Sketch. 24.84KB
PAB Appendix 4C - Quarterly - 30 June 2023PRICE SENSITIVE26/07/23 download Created with Sketch. 532.25KB
PAB Notification of cessation of securities - PAB14/07/23 download Created with Sketch. 21.66KB
PAB Notification of Expiry of PABO Listed Options03/07/23 download Created with Sketch. 782.4KB
PAB PAT-DX1 GLP toxicology reports receivedPRICE SENSITIVE24/05/23 download Created with Sketch. 218.67KB
PAB Notification regarding unquoted securities - PAB11/05/23 download Created with Sketch. 31.66KB
PAB Appendix 4C - Quarterly - 31 March 2023PRICE SENSITIVE24/04/23 download Created with Sketch. 522.86KB
PAB Notification of cessation of securities - PAB18/04/23 download Created with Sketch. 23.59KB
PAB Two new deoxymab patents granted in the USAPRICE SENSITIVE17/04/23 download Created with Sketch. 293.01KB
PAB Updated guidance for PAT-DX1 phase 1 clinical studyPRICE SENSITIVE31/03/23 download Created with Sketch. 246KB
PAB New PAT-DX3 data demonstrates synthetic lethalityPRICE SENSITIVE14/03/23 download Created with Sketch. 366.75KB
PAB Appendix 4D - Half Year Accounts - 31 December 2022PRICE SENSITIVE24/02/23 download Created with Sketch. 1.27MB
PAB Application for quotation of securities - PAB16/02/23 download Created with Sketch. 24.79KB
PAB Change in substantial holding15/02/23 download Created with Sketch. 211.53KB
PAB Change in substantial holding03/02/23 download Created with Sketch. 278.67KB
PAB Change in substantial holding03/02/23 download Created with Sketch. 362.43KB
PAB Appendix 4C - Quarterly - 31 December 2022PRICE SENSITIVE31/01/23 download Created with Sketch. 566.94KB
PAB Patrys Receives R&D Tax Incentive RefundPRICE SENSITIVE30/01/23 download Created with Sketch. 216.54KB
PAB Response to ASX Price QueryPRICE SENSITIVE14/12/22 download Created with Sketch. 412.59KB
PAB Investor Webinar Presentation24/11/22 download Created with Sketch. 6.14MB
PAB Final Director's Interest Notice17/11/22 download Created with Sketch. 369.13KB
PAB Initial Director's Interest Notice17/11/22 download Created with Sketch. 338.61KB
PAB Notification regarding unquoted securities - PAB17/11/22 download Created with Sketch. 28.43KB
PAB Results of Annual General Meeting16/11/22 download Created with Sketch. 582.52KB
PAB Chairman's Address and CEO Presentation to 2022 AGM16/11/22 download Created with Sketch. 11.39MB
PAB Patrys Appoints Dr Charmaine Gittleson as Chairman16/11/22 download Created with Sketch. 251.91KB
PAB Appendix 4C - Quarterly - 30 September 2022PRICE SENSITIVE28/10/22 download Created with Sketch. 471.72KB
PAB PAT DX3 Crosses Blood Brain Barrier in Healthy AnimalsPRICE SENSITIVE17/10/22 download Created with Sketch. 194.16KB
PAB Notification of cessation of securities - PAB14/10/22 download Created with Sketch. 21.59KB
PAB Notice of Annual General Meeting/Proxy Form13/10/22 download Created with Sketch. 1.03MB
PAB Final Director's Interest Notice06/09/22 download Created with Sketch. 377.66KB
PAB Investor presentation01/09/22 download Created with Sketch. 14.22MB
PAB Initial Director's Interest Notice31/08/22 download Created with Sketch. 286.2KB
PAB Appointment of Non-Executive Director31/08/22 download Created with Sketch. 215.12KB
PAB Appendix 4G and Corporate Governance Statement30/08/22 download Created with Sketch. 755.5KB
PAB Appendix 4E and 2022 Annual ReportPRICE SENSITIVE30/08/22 download Created with Sketch. 12.04MB
PAB PAT-DX1 From Engineering Run Meets all Specification TestsPRICE SENSITIVE30/08/22 download Created with Sketch. 258.5KB
PAB New Research Grant For Deoxymabs in Metastatic Breast CancerPRICE SENSITIVE26/08/22 download Created with Sketch. 223.85KB
PAB PAT-DX1/Radiation Combination Improves Brain Cancer SurvivalPRICE SENSITIVE10/08/22 download Created with Sketch. 446.28KB
PAB Retirement of Non-Executive Chair08/08/22 download Created with Sketch. 220.01KB
PAB Appendix 4C - Quarterly - 30 June 2022PRICE SENSITIVE28/07/22 download Created with Sketch. 567.83KB
PAB Change in substantial holding27/07/22 download Created with Sketch. 357.05KB
PAB PAT-DX1 Engineering Run Successfully CompletedPRICE SENSITIVE04/07/22 download Created with Sketch. 220.68KB
PAB New Mechanism By Which PAT-DX1 May Reduce Cancer MetastasisPRICE SENSITIVE14/06/22 download Created with Sketch. 295.27KB
PAB CBCF funding to support deoxymab brain cancer developmentPRICE SENSITIVE03/06/22 download Created with Sketch. 308.87KB
PAB Patrys CEO to present at Bioshares Biotech Summit11/05/22 download Created with Sketch. 15.42MB
PAB Appendix 4C - Quarterly - 31 March 2022PRICE SENSITIVE28/04/22 download Created with Sketch. 504.72KB
PAB Patrys strengthens executive team on path to clinic26/04/22 download Created with Sketch. 221.07KB
PAB Section 708A Cleansing Statement14/04/22 download Created with Sketch. 166.29KB
PAB Application for quotation of securities - PAB14/04/22 download Created with Sketch. 24.9KB
PAB Stable Cell Line for Production of PAT-DX3 EstablishedPRICE SENSITIVE28/02/22 download Created with Sketch. 188.9KB
PAB Appendix 4D - Half Year Accounts - 31 December 2021PRICE SENSITIVE24/02/22 download Created with Sketch. 1.15MB
PAB Application for quotation of securities - PAB08/02/22 download Created with Sketch. 24.77KB
PAB Appendix 4C - Quarterly - 31 December 2021PRICE SENSITIVE31/01/22 download Created with Sketch. 311.35KB
PAB Patrys Receives R&D Tax Incentive RefundPRICE SENSITIVE24/01/22 download Created with Sketch. 161.41KB
PAB PAT-DX1 engineering updatePRICE SENSITIVE24/01/22 download Created with Sketch. 145.66KB
PAB Ceasing to be a substantial holder from MQG09/12/21 download Created with Sketch. 399.92KB
PAB Ceasing to be a substantial holder08/12/21 download Created with Sketch. 828.08KB
PAB Section 708A Cleansing Statement07/12/21 download Created with Sketch. 183.19KB
PAB Application for quotation of securities - PAB07/12/21 download Created with Sketch. 24.6KB
PAB Change of Director's Interest Notices x206/12/21 download Created with Sketch. 502.64KB
PAB Application for quotation of securities - PAB06/12/21 download Created with Sketch. 24.8KB
PAB Rights Issue Results and Shortfall NotificationPRICE SENSITIVE02/12/21 download Created with Sketch. 192.35KB
PAB Notification regarding unquoted securities - PAB23/11/21 download Created with Sketch. 31.57KB
PAB Change of Director's Interest Notice19/11/21 download Created with Sketch. 183.96KB
PAB Notification regarding unquoted securities - PAB18/11/21 download Created with Sketch. 27.44KB
PAB Notification regarding unquoted securities - PAB18/11/21 download Created with Sketch. 28.99KB
PAB Becoming a substantial holder from MQG11/11/21 download Created with Sketch. 481.41KB
PAB Dispatch of Offer Letter to Eligible Shareholders09/11/21 download Created with Sketch. 165.5KB
PAB Letter to Ineligible Shareholders09/11/21 download Created with Sketch. 118.97KB
PAB Letter to Eligible Shareholders - Entitlement Offer09/11/21 download Created with Sketch. 190.72KB
PAB Rights Issue Offer DocumentPRICE SENSITIVE09/11/21 download Created with Sketch. 356.15KB
PAB Notice under Section 708AA(2)(F) - Entitlement Offer09/11/21 download Created with Sketch. 232.58KB
PAB Application for quotation of securities - PAB08/11/21 download Created with Sketch. 25.4KB
PAB Section 708A Cleansing Statement08/11/21 download Created with Sketch. 192.73KB
PAB Results of Annual General Meeting05/11/21 download Created with Sketch. 403.96KB
PAB Chairman's Address and CEO Presentation to 2021 AGM05/11/21 download Created with Sketch. 1.2MB
PAB Change of Director's Interest Notice
22/03/24 download Created with Sketch. 193.98KB
PAB Notification of cessation of securities - PAB
22/03/24 download Created with Sketch. 12.8KB
PAB Presentation to highlight broader potential of Deoxymabs
04/03/24 download Created with Sketch. 217.21KB
PAB Appendix 4D - Half Year Accounts - 31 December 2023
23/02/24PRICE SENSITIVE download Created with Sketch. 457.19KB
PAB Appendix 4C - Quarterly - 31 December 2023
23/01/24PRICE SENSITIVE download Created with Sketch. 517.63KB
PAB Change of Director's Interest Notice
22/12/23 download Created with Sketch. 247.88KB
PAB GMP Production of PAT-DX1 Next Quarter
13/12/23PRICE SENSITIVE download Created with Sketch. 217.51KB
PAB Change of Director's Interest Notices x2
29/11/23 download Created with Sketch. 392.63KB
PAB Notification of cessation of securities - PAB
29/11/23 download Created with Sketch. 21.63KB
PAB Amended Constitution
15/11/23 download Created with Sketch. 1.23MB
PAB Results of Annual General Meeting
15/11/23 download Created with Sketch. 582.64KB
PAB Chair's Address and CEO Presentation to 2023 AGM
15/11/23 download Created with Sketch. 8.36MB
PAB Notification of Expiry of PABOA Listed Options
13/11/23 download Created with Sketch. 369.9KB
PAB Patrys Receives R&D Tax Incentive Refund
08/11/23PRICE SENSITIVE download Created with Sketch. 217KB
PAB Appendix 4C - Quarterly - 30 September 2023
20/10/23PRICE SENSITIVE download Created with Sketch. 487.36KB
PAB Data to be presented at leading brain cancer conference
19/10/23 download Created with Sketch. 281.69KB
PAB Notice of Annual General Meeting/Proxy Form
12/10/23 download Created with Sketch. 712.96KB
PAB Final Director's Interest Notice
20/09/23 download Created with Sketch. 372.26KB
PAB Retirement of Non-Executive Director
14/09/23 download Created with Sketch. 218.44KB
PAB Appendix 4G and Corporate Governance Statement
28/08/23 download Created with Sketch. 781.65KB
PAB Appendix 4E and 2023 Annual Report
28/08/23PRICE SENSITIVE download Created with Sketch. 11.45MB
PAB Change of Director's Interest Notice
11/08/23 download Created with Sketch. 271.58KB
PAB Application for quotation of securities - PAB
08/08/23 download Created with Sketch. 24.94KB
PAB Application for quotation of securities - PAB
26/07/23 download Created with Sketch. 24.84KB
PAB Appendix 4C - Quarterly - 30 June 2023
26/07/23PRICE SENSITIVE download Created with Sketch. 532.25KB
PAB Notification of cessation of securities - PAB
14/07/23 download Created with Sketch. 21.66KB
PAB Notification of Expiry of PABO Listed Options
03/07/23 download Created with Sketch. 782.4KB
PAB PAT-DX1 GLP toxicology reports received
24/05/23PRICE SENSITIVE download Created with Sketch. 218.67KB
PAB Notification regarding unquoted securities - PAB
11/05/23 download Created with Sketch. 31.66KB
PAB Appendix 4C - Quarterly - 31 March 2023
24/04/23PRICE SENSITIVE download Created with Sketch. 522.86KB
PAB Notification of cessation of securities - PAB
18/04/23 download Created with Sketch. 23.59KB
PAB Two new deoxymab patents granted in the USA
17/04/23PRICE SENSITIVE download Created with Sketch. 293.01KB
PAB Updated guidance for PAT-DX1 phase 1 clinical study
31/03/23PRICE SENSITIVE download Created with Sketch. 246KB
PAB New PAT-DX3 data demonstrates synthetic lethality
14/03/23PRICE SENSITIVE download Created with Sketch. 366.75KB
PAB Appendix 4D - Half Year Accounts - 31 December 2022
24/02/23PRICE SENSITIVE download Created with Sketch. 1.27MB
PAB Application for quotation of securities - PAB
16/02/23 download Created with Sketch. 24.79KB
PAB Change in substantial holding
15/02/23 download Created with Sketch. 211.53KB
PAB Change in substantial holding
03/02/23 download Created with Sketch. 278.67KB
PAB Change in substantial holding
03/02/23 download Created with Sketch. 362.43KB
PAB Appendix 4C - Quarterly - 31 December 2022
31/01/23PRICE SENSITIVE download Created with Sketch. 566.94KB
PAB Patrys Receives R&D Tax Incentive Refund
30/01/23PRICE SENSITIVE download Created with Sketch. 216.54KB
PAB Response to ASX Price Query
14/12/22PRICE SENSITIVE download Created with Sketch. 412.59KB
PAB Investor Webinar Presentation
24/11/22 download Created with Sketch. 6.14MB
PAB Final Director's Interest Notice
17/11/22 download Created with Sketch. 369.13KB
PAB Initial Director's Interest Notice
17/11/22 download Created with Sketch. 338.61KB
PAB Notification regarding unquoted securities - PAB
17/11/22 download Created with Sketch. 28.43KB
PAB Results of Annual General Meeting
16/11/22 download Created with Sketch. 582.52KB
PAB Chairman's Address and CEO Presentation to 2022 AGM
16/11/22 download Created with Sketch. 11.39MB
PAB Patrys Appoints Dr Charmaine Gittleson as Chairman
16/11/22 download Created with Sketch. 251.91KB
PAB Appendix 4C - Quarterly - 30 September 2022
28/10/22PRICE SENSITIVE download Created with Sketch. 471.72KB
PAB PAT DX3 Crosses Blood Brain Barrier in Healthy Animals
17/10/22PRICE SENSITIVE download Created with Sketch. 194.16KB
PAB Notification of cessation of securities - PAB
14/10/22 download Created with Sketch. 21.59KB
PAB Notice of Annual General Meeting/Proxy Form
13/10/22 download Created with Sketch. 1.03MB
PAB Final Director's Interest Notice
06/09/22 download Created with Sketch. 377.66KB
PAB Investor presentation
01/09/22 download Created with Sketch. 14.22MB
PAB Initial Director's Interest Notice
31/08/22 download Created with Sketch. 286.2KB
PAB Appointment of Non-Executive Director
31/08/22 download Created with Sketch. 215.12KB
PAB Appendix 4G and Corporate Governance Statement
30/08/22 download Created with Sketch. 755.5KB
PAB Appendix 4E and 2022 Annual Report
30/08/22PRICE SENSITIVE download Created with Sketch. 12.04MB
PAB PAT-DX1 From Engineering Run Meets all Specification Tests
30/08/22PRICE SENSITIVE download Created with Sketch. 258.5KB
PAB New Research Grant For Deoxymabs in Metastatic Breast Cancer
26/08/22PRICE SENSITIVE download Created with Sketch. 223.85KB
PAB PAT-DX1/Radiation Combination Improves Brain Cancer Survival
10/08/22PRICE SENSITIVE download Created with Sketch. 446.28KB
PAB Retirement of Non-Executive Chair
08/08/22 download Created with Sketch. 220.01KB
PAB Appendix 4C - Quarterly - 30 June 2022
28/07/22PRICE SENSITIVE download Created with Sketch. 567.83KB
PAB Change in substantial holding
27/07/22 download Created with Sketch. 357.05KB
PAB PAT-DX1 Engineering Run Successfully Completed
04/07/22PRICE SENSITIVE download Created with Sketch. 220.68KB
PAB New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis
14/06/22PRICE SENSITIVE download Created with Sketch. 295.27KB
PAB CBCF funding to support deoxymab brain cancer development
03/06/22PRICE SENSITIVE download Created with Sketch. 308.87KB
PAB Patrys CEO to present at Bioshares Biotech Summit
11/05/22 download Created with Sketch. 15.42MB
PAB Appendix 4C - Quarterly - 31 March 2022
28/04/22PRICE SENSITIVE download Created with Sketch. 504.72KB
PAB Patrys strengthens executive team on path to clinic
26/04/22 download Created with Sketch. 221.07KB
PAB Section 708A Cleansing Statement
14/04/22 download Created with Sketch. 166.29KB
PAB Application for quotation of securities - PAB
14/04/22 download Created with Sketch. 24.9KB
PAB Stable Cell Line for Production of PAT-DX3 Established
28/02/22PRICE SENSITIVE download Created with Sketch. 188.9KB
PAB Appendix 4D - Half Year Accounts - 31 December 2021
24/02/22PRICE SENSITIVE download Created with Sketch. 1.15MB
PAB Application for quotation of securities - PAB
08/02/22 download Created with Sketch. 24.77KB
PAB Appendix 4C - Quarterly - 31 December 2021
31/01/22PRICE SENSITIVE download Created with Sketch. 311.35KB
PAB Patrys Receives R&D Tax Incentive Refund
24/01/22PRICE SENSITIVE download Created with Sketch. 161.41KB
PAB PAT-DX1 engineering update
24/01/22PRICE SENSITIVE download Created with Sketch. 145.66KB
PAB Ceasing to be a substantial holder from MQG
09/12/21 download Created with Sketch. 399.92KB
PAB Ceasing to be a substantial holder
08/12/21 download Created with Sketch. 828.08KB
PAB Section 708A Cleansing Statement
07/12/21 download Created with Sketch. 183.19KB
PAB Application for quotation of securities - PAB
07/12/21 download Created with Sketch. 24.6KB
PAB Change of Director's Interest Notices x2
06/12/21 download Created with Sketch. 502.64KB
PAB Application for quotation of securities - PAB
06/12/21 download Created with Sketch. 24.8KB
PAB Rights Issue Results and Shortfall Notification
02/12/21PRICE SENSITIVE download Created with Sketch. 192.35KB
PAB Notification regarding unquoted securities - PAB
23/11/21 download Created with Sketch. 31.57KB
PAB Change of Director's Interest Notice
19/11/21 download Created with Sketch. 183.96KB
PAB Notification regarding unquoted securities - PAB
18/11/21 download Created with Sketch. 27.44KB
PAB Notification regarding unquoted securities - PAB
18/11/21 download Created with Sketch. 28.99KB
PAB Becoming a substantial holder from MQG
11/11/21 download Created with Sketch. 481.41KB
PAB Dispatch of Offer Letter to Eligible Shareholders
09/11/21 download Created with Sketch. 165.5KB
PAB Letter to Ineligible Shareholders
09/11/21 download Created with Sketch. 118.97KB
PAB Letter to Eligible Shareholders - Entitlement Offer
09/11/21 download Created with Sketch. 190.72KB
PAB Rights Issue Offer Document
09/11/21PRICE SENSITIVE download Created with Sketch. 356.15KB
PAB Notice under Section 708AA(2)(F) - Entitlement Offer
09/11/21 download Created with Sketch. 232.58KB
PAB Application for quotation of securities - PAB
08/11/21 download Created with Sketch. 25.4KB
PAB Section 708A Cleansing Statement
08/11/21 download Created with Sketch. 192.73KB
PAB Results of Annual General Meeting
05/11/21 download Created with Sketch. 403.96KB
PAB Chairman's Address and CEO Presentation to 2021 AGM
05/11/21 download Created with Sketch. 1.2MB
(20min delay)
Last
0.9¢
Change
-0.001(10.0%)
Mkt cap ! $18.51M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $6.454K 658.9K

Buyers (Bids)

No. Vol. Price($)
17 5817122 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 2306451 4
View Market Depth
Last trade - 14.14pm 29/03/2024 (20 minute delay) ?
Last
0.9¢
  Change
-0.001 ( 10.0 %)
Open High Low Volume
1.0¢ 1.0¢ 0.9¢ 2467579
Last updated 14.14pm 29/03/2024 ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.